193 related articles for article (PubMed ID: 24936775)
21. Genetic and functional analyses implicate microRNA 499A in bipolar disorder development.
Tielke A; Martins H; Pelzl MA; Maaser-Hecker A; David FS; Reinbold CS; Streit F; Sirignano L; Schwarz M; Vedder H; Kammerer-Ciernioch J; Albus M; Borrmann-Hassenbach M; Hautzinger M; Hünten K; Degenhardt F; Fischer SB; Beins EC; Herms S; Hoffmann P; Schulze TG; Witt SH; Rietschel M; Cichon S; Nöthen MM; Schratt G; Forstner AJ
Transl Psychiatry; 2022 Oct; 12(1):437. PubMed ID: 36207305
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide burden of deleterious coding variants increased in schizophrenia.
Loohuis LMO; Vorstman JAS; Ori AP; Staats KA; Wang T; Richards AL; Leonenko G; Walters JT; DeYoung J; ; Cantor RM; Ophoff RA
Nat Commun; 2015 Jul; 6():7501. PubMed ID: 26158538
[TBL] [Abstract][Full Text] [Related]
23. Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders.
Muiños-Gimeno M; Guidi M; Kagerbauer B; Martín-Santos R; Navinés R; Alonso P; Menchón JM; Gratacòs M; Estivill X; Espinosa-Parrilla Y
Hum Mutat; 2009 Jul; 30(7):1062-71. PubMed ID: 19370765
[TBL] [Abstract][Full Text] [Related]
24. Resequencing and association analysis of MIR137 with schizophrenia in a Japanese population.
Egawa J; Nunokawa A; Shibuya M; Watanabe Y; Kaneko N; Igeta H; Someya T
Psychiatry Clin Neurosci; 2013 May; 67(4):277-9. PubMed ID: 23683160
[TBL] [Abstract][Full Text] [Related]
25. Association study of schizophrenia with variants in miR-137 binding sites.
Curtis D; Emmett W
Schizophr Res; 2018 Jul; 197():346-348. PubMed ID: 29158013
[TBL] [Abstract][Full Text] [Related]
26. Effects of MiR-137 genetic risk score on brain volume and cortical measures in patients with schizophrenia and controls.
Cosgrove D; Mothersill DO; Whitton L; Harold D; Kelly S; Holleran L; Holland J; Anney R; ; Richards A; Mantripragada K; Owen M; O'Donovan MC; Gill M; Corvin A; Morris DW; Donohoe G
Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):369-376. PubMed ID: 29418072
[TBL] [Abstract][Full Text] [Related]
27. System-based proteomic and metabonomic analysis of the Df(16)A
Wesseling H; Xu B; Want EJ; Holmes E; Guest PC; Karayiorgou M; Gogos JA; Bahn S
Mol Psychiatry; 2017 Mar; 22(3):384-395. PubMed ID: 27001617
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del.
Zhao D; Lin M; Chen J; Pedrosa E; Hrabovsky A; Fourcade HM; Zheng D; Lachman HM
PLoS One; 2015; 10(7):e0132387. PubMed ID: 26173148
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxia‑inducible factor-2α pathway in vitro and in vivo.
Lu ZJ; Lu LG; Tao KZ; Chen DF; Xia Q; Weng JJ; Zhu F; Wang XP; Zheng P
Mol Med Rep; 2014 Nov; 10(5):2401-8. PubMed ID: 25216407
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of miR‑185 promotes apoptosis of the human gastric cancer cell line MGC803.
Fan L; Tan B; Li Y; Zhao Q; Yuan H; Liu Y; Wang D; Zhang Z
Mol Med Rep; 2018 Feb; 17(2):3115-3122. PubMed ID: 29257260
[TBL] [Abstract][Full Text] [Related]
31. Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis.
Hass J; Walton E; Wright C; Beyer A; Scholz M; Turner J; Liu J; Smolka MN; Roessner V; Sponheim SR; Gollub RL; Calhoun VD; Ehrlich S
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():31-39. PubMed ID: 25598502
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant.
Shi S; Leites C; He D; Schwartz D; Moy W; Shi J; Duan J
J Biol Chem; 2014 May; 289(19):13434-44. PubMed ID: 24675081
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease.
Wen Z; Zhang J; Tang P; Tu N; Wang K; Wu G
Mol Med Rep; 2018 Jan; 17(1):131-137. PubMed ID: 29115479
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑185 regulates transforming growth factor‑β1 and collagen‑1 in hypertrophic scar fibroblasts.
Xiao K; Luo X; Wang X; Gao Z
Mol Med Rep; 2017 Apr; 15(4):1489-1496. PubMed ID: 28259900
[TBL] [Abstract][Full Text] [Related]
35. Targeted resequencing of regulatory regions at schizophrenia risk loci: Role of rare functional variants at chromatin repressive states.
González-Peñas J; Amigo J; Santomé L; Sobrino B; Brenlla J; Agra S; Paz E; Páramo M; Carracedo Á; Arrojo M; Costas J
Schizophr Res; 2016 Jul; 174(1-3):10-16. PubMed ID: 27066855
[TBL] [Abstract][Full Text] [Related]
36. miR‑185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2.
Liu C; Cai L; Li H
Mol Med Rep; 2019 Sep; 20(3):2774-2782. PubMed ID: 31524259
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA Dysregulation, Gene Networks, and Risk for Schizophrenia in 22q11.2 Deletion Syndrome.
Merico D; Costain G; Butcher NJ; Warnica W; Ogura L; Alfred SE; Brzustowicz LM; Bassett AS
Front Neurol; 2014; 5():238. PubMed ID: 25484875
[TBL] [Abstract][Full Text] [Related]
38. Brain expressed microRNAs implicated in schizophrenia etiology.
Hansen T; Olsen L; Lindow M; Jakobsen KD; Ullum H; Jonsson E; Andreassen OA; Djurovic S; Melle I; Agartz I; Hall H; Timm S; Wang AG; Werge T
PLoS One; 2007 Sep; 2(9):e873. PubMed ID: 17849003
[TBL] [Abstract][Full Text] [Related]
39. Novel missense SETD1A variants in Japanese patients with schizophrenia: Resequencing and association analysis.
Morikawa R; Watanabe Y; Igeta H; Arta RK; Ikeda M; Okazaki S; Hoya S; Saito T; Otsuka I; Egawa J; Tanifuji T; Iwata N; Someya T
Psychiatry Res; 2022 Apr; 310():114481. PubMed ID: 35235885
[TBL] [Abstract][Full Text] [Related]
40. Genes in immune pathways associated with abnormal white matter integrity in first-episode and treatment-naïve patients with schizophrenia.
Xiang B; Wang Q; Lei W; Li M; Li Y; Zhao L; Ma X; Wang Y; Yu H; Li X; Meng Y; Guo W; Deng W; Ren H; Li T
Br J Psychiatry; 2019 May; 214(5):281-287. PubMed ID: 30722794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
